David L. Hallal's Insider Trades & SAST Disclosures
David L. Hallal's most recent trade in Scholar Rock Holding Corp was a trade of 275,167 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David L. Hallal.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | David L. Hallal | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 275,167 | 275,167 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | David L. Hallal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 1,250,000 | 1,804,095 (6%) | 4% | 0 | Common Stock | |
| Scholar Rock Holding Corp | David L. Hallal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 250,000 | 554,095 (1%) | 0% | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 13,500 | 304,095 (1%) | 0% | 0 | Common Stock | |
| Seer Inc - Ordinary Shares... | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 58,178 | 355,128 | - | 0 | Class A Common Stock | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,200 | 24,200 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | David L. Hallal | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 2,143,662 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges